Legend Biotech Corp Increase Decrease Through Net Exchange Differences Property Plant And Equipment
Legend Biotech Corp (LEGN) reported Increase Decrease Through Net Exchange Differences Property Plant And Equipment of $1.40 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-10.
Financial Statements › Notes
ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment · last filed 2026-03-10
- Legend Biotech Corp increase decrease through net exchange differences property plant and equipment for the quarter ending 2024-12-31 was -$2.29M, a 328.13% decline year-over-year.
- Legend Biotech Corp increase decrease through net exchange differences property plant and equipment for the quarter ending 2024-09-30 was $1.06M, a 247.39% increase year-over-year.
- Legend Biotech Corp increase decrease through net exchange differences property plant and equipment for the quarter ending 2024-06-30 was -$274.00K.
- Legend Biotech Corp increase decrease through net exchange differences property plant and equipment for the quarter ending 2024-03-31 was -$194.00K.
| Period end | Increase Decrease Through Net Exchange Differences Property Plant And Equipment 3 month | Increase Decrease Through Net Exchange Differences Property Plant And Equipment 6 month | Increase Decrease Through Net Exchange Differences Property Plant And Equipment 9 month | Increase Decrease Through Net Exchange Differences Property Plant And Equipment 12 month | Increase Decrease Through Net Exchange Differences Property Plant And Equipment 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | $1.40M 20-F · filed 2026-03-10 | ||||
| 2024-12-31 | -$2.29M derived: 20-F 12 month − 6-K 9 month · filed 2026-03-10 | -$1.23M derived: sum of 2 quarters · filed 2026-03-10 | -$1.51M derived: sum of 3 quarters · filed 2026-03-10 | -$1.70M 20-F · filed 2026-03-10 | -$1.72M 20-F · filed 2025-03-11 |
| 2024-09-30 | $1.06M derived: 6-K 9 month − 6-K 6 month · filed 2024-11-12 | $789.00K derived: sum of 2 quarters · filed 2024-11-12 | $595.00K 6-K · filed 2024-11-12 | $1.60M derived: sum of 4 quarters · filed 2025-03-11 | |
| 2024-06-30 | -$274.00K derived: 6-K 6 month − 6-K 3 month · filed 2024-08-09 | -$468.00K 6-K · filed 2024-08-09 | $538.00K derived: sum of 3 quarters · filed 2025-03-11 | $844.00K derived: sum of 4 quarters · filed 2025-03-11 | |
| 2024-03-31 | -$194.00K 6-K · filed 2024-05-13 | $812.00K derived: sum of 2 quarters · filed 2025-03-11 | $1.12M derived: sum of 3 quarters · filed 2025-03-11 | ||
| 2023-12-31 | $1.01M derived: 20-F 12 month − 6-K 9 month · filed 2025-03-11 | $1.31M derived: sum of 2 quarters · filed 2025-03-11 | -$638.00K 20-F · filed 2025-03-11 | ||
| 2023-09-30 | $306.00K derived: 6-K 9 month − 6-K 6 month · filed 2023-11-20 | -$1.64M 6-K · filed 2023-11-20 | |||
| 2023-06-30 | -$1.95M 6-K · filed 2023-08-15 | ||||
| 2022-12-31 | -$3.84M 20-F · filed 2024-03-19 | ||||
| 2021-12-31 | $537.00K 20-F · filed 2023-03-30 | $391.00K 20-F · filed 2022-03-31 | |||
| 2020-12-31 | $1.37M 20-F/A · filed 2023-02-17 | ||||
| 2019-12-31 | -$315.00K 20-F · filed 2021-04-02 |